YEM Search

搜索结果

SLC7A9

靶点ID:TCMBANKGE013973

靶点别名:BAT1; CSNU3

靶点描述:solute carrier family 7 member 9

染色体:19

染色体位置:19q13.11

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:11067

OMIM_Link:604144

Ensembl_Link:ENSG00000021488

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN057905	ferrum	iron	Fe	55.84 g/mol	[Fe]
TCMBANKIN057930	D-Cystine	L-Dicysteine; CHEBI:16283; Cystine,d; C7602_SIGMA; Cystine D-form; C8755_SIGMA; Cystine, D-; 2-amino-3-(2-amino-2-carboxy-ethyl)disulfanyl-propanoic acid; Cystine (USAN); 56-89-3; (R,R)-3,3'-dithiobis(2-aminopropanoic acid); 3,3'-Dithiobis-L-alanine; Gelucystine; 349-46-2; L-Cystine (9CI); bis(beta-amino-beta-carboxyethyl) disulfide; L-alpha-Diamino-beta-dithiolactic acid; C5735_SIGMA; (2R)-2-amino-3-[(2R)-2-amino-3-hydroxy-3-oxopropyl]disulfanylpropanoic acid; D03636; EINECS 206-486-2; (2R)-2-amino-3-[(2R)-2-amino-3-hydroxy-3-oxo-propyl]disulfanyl-propanoic acid; 30199_FLUKA; Cystine, L- (8CI); (2R,2'R)-3,3'-disulfanediylbis(2-aminopropanoic acid); NCGC00166006-01; (R,R)-3,3'-Dithiobis(2-aminopropionicacid); C00491; (2R)-2-amino-3-[(2R)-2-amino-3-hydroxy-3-keto-propyl]disulfanyl-propionic acid;cystine	C6H12N2O4S2	240.3	C(C(C(=O)O)N)SSCC(C(=O)O)N
TCMBANKIN057965	arginine	L(+ )-arginine;EINECS 230-571-3; (2S)-2-amino-5-guanidino-pentanoic acid; EINECS 200-811-1; (S)-2-Amino-5-guanidinovaleric acid; DL-Arginine; (L)-Arginine; Arginine hydrochloride(USAN); 1-Amino-4-guanidovaleric acid; L-Ornithine, N5-(aminoiminomethyl)-; W381918_ALDRICH; (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid; Arginine [USAN:INN]; S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; L-Arginine, labeled with tritium; AI3-24165; AIDS-121865; (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; NSC203450 (HYDROCHLORIDE); A5006_SIAL; (+-)-Arginine; L-Norvaline, 5-((aminoiminomethyl)amino)-; AIDS121865; Lopac0_000077; Tocris-0663; Arginine (VAN); 4455-52-1; CCRIS 3609; BRN 1725413; NCGC00015064-01; (2S)-2-amino-5-(carbamimidamido)pentanoic acid; (2S)-2-amino-5-guanidinopentanoic acid; D02982; Argininum [INN-Latin]; C00062; 7200-25-1; A8094_SIGMA; 11009_FLUKA; Poly(L-arginine); (2S)-2-amino-5-guanidino-valeric acid; Lopac-A-5006; NSC 206269; HSDB 1429; CHEBI:16467; L-Arginine, homopolymer; L-Arginine (9CI); Arginina [INN-Spanish]; 4-04-00-02648 (Beilstein Handbook Reference); (S)-2-amino-5-guanidinopentanoic acid; (S)-2-Amino-5-((aminoiminomethyl)amino)pentanoic acid; Arginine, L- (8CI); L-Arginine (JP15); EU-0100077; L-alpha-Amino-delta-guanidinovaleric acid; NSC7914 (HYDROCHLORIDE); Arginine (USP); 1119-34-2 (HYDROCHLORIDE); Pentanoic acid, 2-amino-5-((aminoiminomethyl)amino)-, (S)-; L-Arg; L-Norvaline, 5-[(aminoiminomethyl)amino]-; 142-49-4; A4474_SIAL; InChI=1/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s; L-Arginin; Arginine, DL-; NCGC00024715-01;AC1ODX8E; [(4S)-5-amino-4-azaniumyl-5-oxopentyl]-(diaminomethylidene)azanium; [AMINO({[(4S)-4-AMMONIO-4-CARBAMOYLBUTYL]AMINO})METHYLIDENE]AZANIUM	C6H14N4O2	174.2 g/mol	C(CC(C(=O)O)N)CN=C(N)N
TCMBANKIN057975	lysine acid		C6H14N2O2	146.19 g/mol	C(CCN)CC(C(=O)O)N
TCMBANKIN061102	LFA		C20H42	282.55 g/mol	CCCCCCCCCCCCCCCCCCCC

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000023		Skin and Connective Tissue Diseases; Immune System Diseases	Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI000054		Nervous System Diseases; Mental Disorders	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI000074		Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases	-	Disease or Syndrome	disease
TCMBANKDI014161		Stomatognathic Diseases	Abnormality of the immune system; Abnormality of head or neck	Disease or Syndrome	group
TCMBANKDI015829		Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases	Abnormality of the genitourinary system	Disease or Syndrome	disease
TCMBANKDI016684		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases	-	Disease or Syndrome	disease
TCMBANKDI017837		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI018761		-	-	Diagnostic Procedure	phenotype
TCMBANKDI021339		Hemic and Lymphatic Diseases	Abnormality of blood and blood-forming tissues	Disease or Syndrome	group
TCMBANKDI028664		-	-	Finding	phenotype
TCMBANKDI029321		Cardiovascular Diseases	-	Disease or Syndrome	group
TCMBANKDI030416		Infections	-	Disease or Syndrome	disease